*Optimal dilutions/concentrations should be determined by the researcher.
Not tested in other applications.
H1299 , HCT116 , C2C12 , C2C12+AEA10mM , mouse brain
Rat, Bovine, Chicken, Rhesus Monkey(>80% identity)
1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
1.98mg/ml(Please refer to the vial label for the specific concentration.)
Recombinant protein encompassing a sequence within the N-terminus region of human PI3K p110 alpha. The exact sequence is proprietary.
Purified by antigen-affinity chromatography.
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
MGC142161 antibody, MGC142163 antibody, PI3K antibody, p110-alpha antibody, PIK3CA antibody, serine/threonine protein kinase PIK3CA antibody, "phosphatidylinositol 3-kinase, catalytic, 110-KD, alpha antibody", ptdIns-3-kinase subunit p110-alpha antibody, PI3-kinase subunit alpha antibody, PI3Kalpha antibody, PtdIns-3-kinase p110 antibody, "phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform antibody", phosphoinositide-3-kinase catalytic alpha polypeptide antibody, "phosphatidylinositol-4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha antibody", PI3-kinase p110 subunit alpha antibody, PI3K-alpha antibody, "phosphatidylinositol 3-kinase, catalytic, alpha polypeptide antibody", p110alpha antibody, "phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, alpha isoform antibody", ptdIns-3-kinase subunit alpha antibody, "phosphoinositide-3-kinase, catalytic, alpha polypeptide antibody"
Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. [provided by RefSeq]